Investing.com -- Celldex Therapeutics Inc (NASDAQ:CLDX) reported third-quarter earnings that fell short of analyst expectations on Monday, as the company continues to invest heavily in its pipeline of ...

Strong execution and continued progress across pipeline Positive Phase 2 barzolvolimab data in Chronic Spontaneous Urticaria ...

Celldex (NASDAQ: CLDX) today announced the appointment of Teri Lawver as Senior Vice President, Chief Commercial Officer. Ms.

Fox Factory Holding's stock has recently seen its consensus analyst price target revised downward, dropping from $33 to approximately $28.14. This shift comes as analysts balance optimism about ...

The apparent low bid for a riverfront project on the city’s lower West Side is more than $200,000 less than the estimate for the work. The bids will be reviewed and the apparent low bid from Marucci & ...

As of Friday, November 07, Fox Factory Holding Corp.’s FOXF share price has dipped by 24.86%, which has investors questioning ...

Roth Capital analyst Scott Stember lowered the firm’s price target on Fox Factory (FOXF) to $21 from $30 and keeps a Neutral rating on the shares.

Q3 2025 Management View CEO Michael Dennison reported net sales of $376.4 million for the quarter, reflecting 5% year-over-year growth and highlighted "growth in both AAG and PVG." He stated, "Our SSG ...

Fox Factory reports its net sales were up 4.8% in the third quarter, largely thanks to the company's powered-vehicle ...

Fox Factory Holding Corp. reported profits in the third quarter missed plan due to cautious ordering by dealers in its Specialty Sports Group (SSG) segment, which includes cycling brands such as Fox ...

The Baton Rouge Business Report’s 40 Under 40 list recognizes emerging leaders making a significant impact on the Capital ...